SNDX icon

Syndax Pharmaceuticals

115 hedge funds and large institutions have $861M invested in Syndax Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 54 increasing their positions, 31 reducing their positions, and 26 closing their positions.

Holders
115
Holders Change
-15
Holders Change %
-11.54%
% of All Funds
2.01%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
11
Increased
54
Reduced
31
Closed
26
Calls
$1.31M
Puts
$1.99M
Net Calls
-$677K
Net Calls Change
-$2.41M
Name Holding Trade Value Shares
Change
Shares
Change %
IC
126
Ikarian Capital
Texas
-$914K -40,913 Closed
CS
127
Candriam SCA
Luxembourg
-$548K -25,671 Closed
MWNA
128
Marshall Wace North America
New York
-$541K -24,190 Closed
Jane Street
129
Jane Street
New York
-$425K -19,033 Closed
AQR Capital Management
130
AQR Capital Management
Connecticut
-$418K -18,680 Closed
ECM
131
ExodusPoint Capital Management
New York
-$232K -10,359 Closed
AG
132
Algert Global
California
-$214K -9,550 Closed
SG Americas Securities
133
SG Americas Securities
New York
-$175K -7,832 Closed
Pacer Advisors
134
Pacer Advisors
Pennsylvania
-$76K -3,402 Closed
Bank of Montreal
135
Bank of Montreal
Ontario, Canada
-$52K -2,256 Closed
RFA
136
Reilly Financial Advisors
California
-$45K -2,000 Closed
CG
137
Cutler Group
California
-$33K -1,500 Closed
DWA
138
Dorsey Wright & Associates
California
-$31.5K -1,410 Closed
FC
139
FORA Capital
Florida
-$29K -1,306 Closed
MFIM
140
Mesirow Financial Investment Management
Illinois
-$20K -894 Closed
QT
141
Quantbot Technologies
New York
-$15K -700 Closed